-+ 0.00%
-+ 0.00%
-+ 0.00%

Sociedad Química (SQM) Q3 2026 Earnings Call Transcript

The Motley Fool·11/18/2026 19:45:05
Listen to the news
Logo of jester cap with thought bubble.

Image source: The Motley Fool.

DATE

Wed, Nov. 18, 2026

CALL PARTICIPANTS

  • Investor Relations - Megan Suitor
  • Chief Executive Officer - Ricardo Ramos
  • Chief Financial Officer - Gerardo Illanes
  • CEO of the Novandino Division - Carlos Diaz
  • CEO of the SQM Division - Pablo Altimiras
  • CEO of the International Lithium Division - Mark Fones
  • Commercial Vice President of the Novandino Division - Felipe Smith
  • Vice President of Strategy and Development of the Novandino Division - Pablo Hernandez
  • Commercial Vice President for Plant Nutrition and Specialty Products - Juan Pablo Bellolio
  • CFO of the International Lithium Division - Alvaro Araya
  • Commercial Vice President of the International Lithium Division - Andres Fontannaz
  • Head of Studies of the International Lithium Division - Max Vial

TAKEAWAYS

  • Net Income -- Close to $1.6 billion for the first nine months of the year, representing an increase of nearly four times compared to the same period in 2025.
  • Lithium Demand Growth (2026) -- 30% growth projected for the full year, supported by electric vehicle adoption and battery energy storage system expansion.
  • Lithium Market Size (2030) -- Over 3 million metric tons expected by the end of the decade, driven by increasing lithium content in vehicles and market expansion beyond China.
  • Lithium Demand Forecast (2027) -- 2.5 million metric tons, representing growth of 15% to 20% over 2026 levels.
  • Iodine Demand Growth -- Over 3% annually for 2026 and 2027, primarily supported by demand for x-ray contrast media.
  • Specialty Plant Nutrition Sales Volume -- 5% growth projected for the full year, representing a downward revision from previous expectations due to lower demand following price increases.
  • Novandino Lithium Production (Q3) -- 75,000 metric tons, a figure consistent with output reported in the second quarter.
  • Novandino Annual Production (2026) -- 290,000 metric tons, with all production originating from the Salar de Atacama operations.
  • Novandino Production Target (2027) -- Over 300,000 metric tons, reflecting anticipated gains from efficiency programs and recovery initiatives.
  • Three-Year Capital Expenditures -- 3 billion from 2026 to 2028, reflecting an average annual investment of $1 billion to support competitive projects.
  • Year-to-Date Capital Expenditures -- Under $500 million for the first three quarters, reflecting project schedules despite lower current lithium prices.
  • Lithium Sulfate Production (2026) -- 160,000 metric tons, which is equivalent to approximately 80,000 metric tons of lithium carbonate.
  • China Factory Output -- Over 20,000 metric tons as lithium carbonate equivalent, with the remaining sulfate production processed through third-party tollers in China.
  • Mount Holland Spodumene Production -- 175,000 to 185,000 metric tons of 6% concentrate for 2026, with the plant operating at or above nameplate capacity.
  • Energy Storage System (ESS) Demand -- 15% growth projected for 2027, maintaining a core role in lithium consumption despite competition from alternative technologies.
  • Electric Vehicle (EV) Demand (2027) -- 15% to 20% growth projected, aligned with broader market diversification.
  • Potash Segment Strategy -- Potash is treated as a byproduct to lithium production, with volumes expected to decrease as the company prioritizes supply for its internal potassium nitrate business.

Need a quote from a Motley Fool analyst? Email pr@fool.com

RISKS

  • Ramos stated, "higher prices -- fertilizer prices have resulted in lower customer demand," leading management to revise its full-year sales volume growth outlook for the specialty plant nutrition business to 5%.
  • Ramos noted that "lithium market today -- price today is significantly lower since the peak observed during the second quarter," although the company expects a future price increase based on demand fundamentals.

SUMMARY

Sociedad Química y Minera de Chile (NYSE:SQM) reported a significant increase in net income during the first nine months of the year, driven by steady demand across its primary lithium and iodine business lines. Management highlighted that while lithium prices have moderated from earlier peaks, global demand continues to expand through electric vehicle adoption and the growth of battery energy storage systems. The company is maintaining its long-term capital expenditure plans and production efficiency initiatives despite recent pricing fluctuations in the fertilizer and lithium markets. Executive commentary focused on the strategic positioning of Chilean and Australian assets to meet projected global demand growth through the end of the decade.

  • Pablo Hernandez noted that lithium maintains natural advantages in energy density and production cost over sodium-ion technology.
  • Management indicated that current lithium prices sit below the incentive price required to stimulate new supply to meet long-term demand.
  • The Novandino Division reported that lithium costs for the third quarter remained stable compared to the second quarter.
  • Mark Fones stated that the mine and concentrator at Mount Holland are performing in line with top Western Australian producers regarding cost competitiveness.
  • The company reported that its lithium hydroxide ramp-up is progressing with battery-grade product quality increasing on a monthly basis.

INDUSTRY GLOSSARY

  • BESS: Battery Energy Storage System.
  • ESS: Energy Storage System.
  • Iodine Derivatives: Chemical compounds derived from iodine used in medical imaging, antiseptics, and pharmaceuticals.
  • LCE: Lithium Carbonate Equivalent, a standardized measure for comparing different lithium products.
  • MOP: Muriate of Potash, a common potassium fertilizer also known as potassium chloride.
  • NPK: Compound fertilizers containing nitrogen, phosphorus, and potassium.
  • Salar de Atacama: A salt flat in northern Chile that serves as a primary source for the company's lithium and potassium production.
  • SOP: Sulfate of Potash, a premium potassium fertilizer.
  • Spodumene: A lithium-bearing mineral typically found in hard rock deposits, such as those at the Mount Holland project.
  • X-ray contrast media: Medical substances used to improve the visibility of internal bodily structures during imaging procedures, a major driver of iodine demand.

Full Conference Call Transcript

Operator: Thank you for standing by. Welcome to SQM Third Quarter 2026 Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. Now it's my pleasure to turn the call to Megan Suitor with Investor Relations. Please proceed.

Megan Suitor: Good day, and thank you for joining SQM Group's earnings conference call for the third quarter of 2026. This call is being recorded and webcast live. Our earnings press release and the accompanying results presentations are available on our website, where you can also find a link to the webcast. Today's participants include Mr. Ricardo Ramos, Chief Executive Officer; Mr. Gerardo Illanes, Chief Financial Officer; Mr. Carlos Diaz, CEO of the Novandino Division; Mr. Pablo Altimiras, CEO of the SQM Division; Mr. Mark Fones, CEO of the International Lithium Division. Also joining us today are members of our commercial and business intelligence teams. Mr. Felipe Smith, Commercial Vice President of the Novandino Division; Mr.

Pablo Hernandez, Vice President of Strategy and Development of the Novandino Division; Mr. Juan Pablo Bellolio, Commercial Vice President for Plant Nutrition and Specialty Products; Mr. Alvaro Araya, CFO of the International Lithium Division; Mr. Andres Fontannaz, Commercial Vice President of the International Lithium Division; and Mr. Max Vial, Head of Studies of the International Lithium Division. Before we begin, please note that statements made during this call regarding our business outlook, future economic performance, anticipated profitability, revenues, expenses and other financial items, along with expected cost synergies and product or service line growth are considered forward-looking statements under U.S. federal securities laws.

These statements are not historical facts and are subject to risks and uncertainties that could cause actual results to differ materially. We assume no obligation to update these statements, except as required by law. For a full discussion of forward-looking statements, please refer to our earnings press release and presentation. With that, I will now turn the call over to our Chief Executive Officer, Mr. Ricardo Ramos.

Ricardo Ramos: Thank you. Good morning, everyone, and thank you for joining us today. I'm pleased to present SQM Group's third quarter results. We continue to deliver solid performance across our main business lines with positive year-over-year results, reporting close to $1.6 billion as net income during the first 3 quarters of the year, almost 4x higher than the net income reported in the same period in 2025. Starting with Lithium, we continue to see encouraging demand trends and remain extremely confident in the long-term growth prospects of the market. Although lithium market today -- price today is significantly lower since the peak observed during the second quarter, we continue to see healthy demand growth for lithium.

Consequently, it's reasonable to expect prices should increase in the near future. Demand growth is being supported not only by electric vehicle adoption, but also by increasing lithium content in vehicles as the expansion of markets beyond China and the growing contribution of battery energy storage system. We estimate that global lithium demand could grow by approximately 30% in 2026, and we expect the market could surpass 3 million metric tons by 2030. From an operational and commercial perspective, both lithium divisions performed in line with our expectations. Moving to Iodine. We once again delivered solid performance results, supported by healthy market demand and favorable pricing conditions.

Demand for iodine and derivatives continued to be driven primarily by x-ray contrast media. We expect global iodine demand to grow over 3% in both 2026 and 2027, supported by these applications. We remain focused on strengthening our position as a reliable supplier while advancing our operational efficiency and production capacities. Turning to Specialty Plant Nutrition. This business also continued to demonstrate good commercial activity during the third quarter. We saw strong sales across our traditional markets. However, higher prices -- fertilizer prices have resulted in lower customer demand. And as a result, we revised our full year sales volume growth outlook to approximately 5% over last year. Meanwhile, prices have continued to show a positive trend.

Overall, we remain focused on delivering solid operating and commercial performance, maintaining our long-term perspective while preserving financial discipline. Thank you.

Operator: [Operator Instructions] One moment for our first question, please. It comes from the line of Joel Jackson with BMO Capital Markets.

Joel Jackson: Do you hear me? Sorry, do you hear me?

Operator: Yes. Yes, we can hear you. Please proceed.

Joel Jackson: There's a bit of a lag. I'm sorry, I'm sorry. I'll ask them one by one. So we've seen a bit of turn in lithium market, obviously, since the end of the summer or since the summer and prices have come down, a lot of concerns about 2027. I have a question I want to ask, which is how much of the 30% lithium demand growth this year that you project that we're seeing, how much of that 30% has been demand, like end-use consumption versus inventory building? And what do you think demand growth looks like in '27 based on all that you know?

Pablo Hernandez: Joel, this is Pablo Hernandez speaking. So as Ricardo has said, we're very strong on the demand for this year and then the upcoming years. And out of the 30%, we believe most of that has been end customers, as we have seen and you have seen in the market, the inventory levels have dropped during this year. And regarding your question on 2027, we expect growth for the next year in the numbers of close to 2.5 million metric tons of demand, which would represent somewhere in the 15% to 20% growth.

Joel Jackson: Okay. And can you talk about what we're seeing in the market right now? And we all see the inventory numbers, but we see the concerns of 2027. When you think about that 15% to 20% demand growth next year, I mean, how are you baking in some of the concerns on ESS we've seen, be it lower IRRs based on things going on in China, be it some penetration on sodium. How has your ESS view changed versus, say, 6 months ago?

Pablo Hernandez: Yes. So we still remain very strong on the demand for BESS. We expect the growth in the range of 15% for the upcoming year. So we remain very, very confident about the demand on the BESS side. And on your question on sodium ion, indeed, we've seen the development of this new technology. We strongly believe that lithium is very well positioned to continue to grow in this space. And sodium ion, of course, at some point, might take some small spaces in the market, but lithium has some natural advantages in terms of cost, production cost, I mean, and energy density over sodium ion.

Joel Jackson: Okay. Then my final question is sort of tying it together. So you see overall lithium demand growth up next year, 15% to 20%, and you see ESS demand growth as part of that up about 15% next year. That means you see EV demand also up around 15% to 20% next year, correct?

Pablo Hernandez: Yes. You're more or less in that same range, exactly.

Operator: Our next question comes from Lucas Ferreira with JPMorgan.

Lucas Ferreira: Also on the fundamentals of the lithium market, wondering if you can comment on how do you see the lithium inventory situation on the ground in China in different channels, in ports and in the upstream. So how these inventories have been changing over the last few months? If you still see a tight market or wondering how much of that lithium price decline we have been seeing is also influenced by the sentiment on the whole, let's say, downward revision of growth rates or if it's sustained by fundamentals as well in your view. And on the SQM side, I'm wondering if there's any updates to your production expectations or sales expectations for this year.

And wondering if you can also say something about the '27, how you're seeing production sales.

Pablo Hernandez: Lucas, Pablo Hernandez speaking. So on your lithium question, as you mentioned, indeed, during 2026, we have seen a very significant price fluctuation with prices, of course, below the numbers we've seen during mid of the year. But as Ricardo mentioned, we remain very strong on demand. We're very confident in the growth for the next coming years. Ricardo mentioned, demand is expected to be over the 3 million metric tons by 2030. So that shows how much lithium will be required just for the next few years. And additionally, of course, current demand is a more robust one, more robust than the one we had a few years ago. We now have 2 significant drivers, EVs and BESS.

And not only that, we also have a more diverse demand from a global market perspective, which helps absorb, of course, specific market fluctuations. And finally, I would say it's important to also remember that the current price level seems to be sitting below the necessary incentive price required to bring new supply to fulfill this demand. And therefore, we should expect some price increase in the future.

Carlos Diaz Ortiz: This is Carlos Diaz speaking. I'm going to talk about the production for this year and next year from the Novandino Division. For the third quarter, we reached a production close to 75,000. It was quite similar that we reached in the quarter 2. And for this year, we expect to produce close to 290,000 metric tons, all coming from the Salar de Atacama. And for next year, we expect to continue to increase in our efficiency programs and to increase recovery and so on, and more initiative in order to reach a production a little bit over 300,000.

Operator: Our next question comes from the line of Ben Isaacson with Scotiabank.

Ben Isaacson: Can you hear me okay?

Operator: A little far. If you can get closer to the microphone.

Ben Isaacson: Okay. I'm going to -- I'll talk louder. I have three questions. So first question is, if prices stay where they are right now, Gerardo, does the cadence or the timing of your CapEx spend, does that change? Do you start to delay that? And does the financing of that change as well?

Ricardo Ramos: Ben, Ricardo Ramos speaking. Our CapEx, the one that we discussed, I think, last time we have a conference call, we remain the same. We don't foresee any reason to change our capital expenditure considering what is today price environment. We are very, very positive about what's going on in the future. And our CapEx is very full focus in what we think we have a real competitive advantages.

Ben Isaacson: Okay. And my next question is on lithium sulfate. How -- what is the run rate that we should be using on a go-forward basis? And if the economics between your plant and tolling are similar, why do you need the plant? Why don't you just do tolling 100%?

Carlos Diaz Ortiz: So regarding to lithium -- sorry, Carlos Diaz speaking again. Regarding to the lithium sulfate production this year, we expect to produce 160,000. That is more or less equivalent 80,000 as lithium carbonate. And for next year, we expect to increase a little bit that production. And yes, we still -- we have our own factory in China where we produce more than 20,000 as lithium carbonate, and the remaining production is we do through tollers in China. Well, we always are evaluating to increase our capacity in China, in Chile, and there are some under evaluation always, but nothing has been decided yet.

Ben Isaacson: Okay. And my last question is on SPN. Volumes went down, and you talked about farmers pushing back a little bit on higher prices. Can you just give some color and some detail what specific products was it? Was it all MOP? And what were the regions that you saw this pushback in demand? And was it just because MOP prices were high following what China did earlier in the year? And do you expect it to normalize?

Juan Bellolio: Excuse me, Ben, this is Juan Pablo. Could you please repeat the question because we lost the second part?

Ben Isaacson: I'm sorry. The question is on SPN. What specifically were the regions and the products that caused lower volumes? And do you expect that demand to come back?

Juan Bellolio: Okay, Ben, I would say, as you know, we sell in mostly all of the countries, more than 100 countries. So our sales are very diversified and our -- the impact of higher prices in different products has reached, I would say, all markets. It's not that we have one market specifically that rules the decline on volumes. You need to remember also that we sold a huge volume in Q2. So if you consider the balance between Q2 and Q3, it's more or less the same volume than last year, okay? So in terms of our sales in total year, actually, we are still up compared to last year.

So Q3 could be something exceptional, and we expect that Q4 would be more or less similar to what we saw last year. In terms of the higher prices on which products, of course, phosphates are the ones that are making the higher increase affecting our sales of distribution in phosphate products, but also on the NPKs that use phosphate. Those products, I would say, are the ones with a higher impact. And that's why we have compensated this with higher sales on potassium nitrate, our main product. And in terms of the question about MOP, you need to remember that our potash business line consider MOP, but also SOP. The SOP price has gone up during the year.

So -- and the proportion of SOP today is higher than in the past year. So that's why you see that price increase.

Operator: Our next question comes from the line of Corinne Blanchard with Deutsche Bank.

Corinne Blanchard: Maybe I want to go back on the International Lithium Division on Mount Holland. Can you give a little bit more detail or clarity on the expectation for volume for 2027? Because I think based on your commentary so far, it seems like 4Q will be a nice step-up versus the rest of the year. So just wondering if that's continuing to 2027.

Mark Fones: Corinne, this is Mark Fones here. Our guidance for this year in terms of production for the concentrator of Mount Holland continues to be in the same range of between 175,000 and 185,000 tonnes of spodumene concentrate 6%. That's currently working at nameplate capacity or even slightly above nameplate capacity, and we expect the plant to continue working in that perspective for next year. The amount of direct sales out of that is still on question regarding our ramp-up nameplate -- into nameplate for the refinery, and that's a plan that is currently being derived. And once we have a better view on that, we will inform you at that time.

Corinne Blanchard: Okay. And then maybe the second part, I'm sorry if it has been asked, but on the potash, do you guys are still expecting -- like what the strategy is there over '27, '28? I think before you had mentioned you would not have any more -- any potash volume due to the strategy for the lithium side. But can you just give like a better maybe view of the timing? And how do we think about those volumes for next year and '28?

Carlos Diaz Ortiz: Corinne, this is Carlos Diaz of Novandino Division. Well, in Novandino, we're focused to produce lithium as a main product and potash is like a second product or byproduct. And we mainly focus to produce for the production of the potassium nitrate. And we -- when there's some remaining potash, the fertilizer which you can sell in the market. So I'm going to say to Pablo, if you can comment something about that.

Juan Bellolio: Yes, I don't have too much to add. But what Carlos said is right. I mean it's important to understand that we have a contract with Novandino that secures the availability of potash for our potassium nitrate business, which is the main business in agriculture business. And then depending on the production, how is the production and we have availability of potash to direct sales, we will continue with that because we have all the commercial offices to do it, our port and so on. So if we have availability, we will continue selling the product.

Operator: Our next question comes from Isabella Simonato with Bank of America.

Isabella Simonato: I want to go back a little bit on the lithium side. I understand your view about -- your constructive view, right, about the market and demand growth. But more in the short term, right, we are seeing prices coming down. I wonder if you have any sensitivity or view, right, if we should see maybe prices accommodating at a lower level before they move up, or when do you expect to see some sort of inflection point as the demand story continues to play out in 2027.

Pablo Hernandez: Isabella, Pablo Hernandez speaking. As I mentioned earlier, indeed, prices are considerably below what we've seen in the middle of the year. But of course, we remain very confident in the demand. And we don't know when the prices will increase, but we do expect, of course, a price increase in the near future.

Isabella Simonato: And just a follow-up on the potash side, right? I guess we understand that you're structurally reducing potash volumes. But can you give us a sense on maybe how much can we expect for the full year 2027 in terms of potassium chloride volumes?

Juan Bellolio: Isabella, this is Juan Pablo. We are still reviewing with our partners of Novandino, our availability of commercial potash to place into the market. Of course, we believe that as we have been commenting and saying in the past that the volumes are going to go down. We don't know yet at what level, but you can consider that what we have been selling this year is going to be higher than next year.

Operator: Our last question comes from the line of Matheus Moreira with Bradesco BBI.

Matheus Moreira: A couple of questions on my side. First, on the CapEx. I mean, disbursements have been relatively light over the past few quarters. Year-to-date, CapEx below $500 million. I'm just wondering what's the explanation for this lower-than-expected CapEx if maybe the company is adjusting its expenditures to reflect these tougher conditions. And how should we expect CapEx moving in the next few quarters? That's my first question. Then the second question on lithium. I mean, costs were the negative surprise here against our numbers in the quarter. With production pretty much in line with our numbers, we would expect a slightly better cost performance.

Could you help us understand what -- I mean, the main drivers behind the cost performance in the third quarter? And what should we expect for costs going forward? And then if I can squeeze in a last question on your mix, especially in the International Division. I mean, you have the expansion in Mount Holland in the next couple of years. You're also ramping up the refinery in China. I'm just wondering what would be the ideal mix between spodumene and hydroxide in the next couple of years in the International divisions. Those are my questions.

Gerardo Illanes: Matheus, this is Gerardo speaking. Well, regarding your CapEx question, it's true during the first 3 quarters of this year, CapEx was a little bit less than $500 million. What we informed last quarter is that we expect CapEx for the 3 years, '26 to '28 to be in the neighborhood of $3 billion. On average, of course, that's $1 billion per year. During 2026, it's going to be slightly lower than that. But the projects are moving ahead based on the schedule that each of these projects have. And we have no -- I mean, we have not made any changes to the CapEx plan so far.

Carlos Diaz Ortiz: So coming about the lithium cost of the Novandino Division, I can say that we have been able to maintain our very competitive cost position, reducing our cost compared to the last year. And the cost of the third quarter is quite similar to what it was in the second quarter, and we expect the same almost cost during the fourth quarter. And indeed, the next year is going to be, again, at the same level. So we don't expect an increase in the cost in spite of the inflation and the energy cost because we have been able to reduce it and to increase our productivity in order to keep our cost reduction in line.

And again, it's going to be lower compared with last year.

Mark Fones: Matheus, on the International Lithium Division, our costs have remained stable in the last quarters. Our business is well positioned on this market context. As I mentioned before, the mine and concentrator is running at full capacity with competitive costs in line with Western Australian top producers. And the expansion will also provide us further lowering of unit costs into the future. I understand there was another question from your side, but we couldn't hear very well, if you want a follow-up.

Matheus Moreira: No, no. The final question was regarding the mix in the International Division between spodumene and hydroxide. With Mount Holland ramping up -- I mean, with Mount Holland expansion in the next few years and the Chinese refinery ramping up, how do you see the mix evolving between spodumene and hydroxide sales?

Mark Fones: Yes. As I mentioned before, we are committed into the lithium hydroxide ramp-up. The ramp-up is progressing well. We have already a very good product quality in terms of battery grade, which is increasing on a monthly basis. The exact amount of that distribution, which is -- will be either consumed by the Kwinana refinery or direct sales of spodumene concentrate, as I mentioned earlier, that's something that still remains as a matters of planning and budgeting season for Covalent, and we will inform that duly once we have a better idea for next year.

Operator: Thank you so much. And ladies and gentlemen, this will conclude our Q&A session and conference for today. We thank you for participating, and you may now disconnect.

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. Parts of this article were created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.